Literature DB >> 11890892

Monte Carlo docking simulations of cyclomaltoheptaose and dimethyl cyclomaltoheptaose with paclitaxel.

Hyunmyung Kim1, Jungwon Choi, Hyun-Won Kim, Seunho Jung.   

Abstract

The molecular basis for the remarkable enhancement of the solubility of paclitaxel by O-dimethylcyclomaltoheptaose (DM-beta-CD) over cyclomaltoheptaose (beta-cyclodextrin, beta-CD) was investigated with Monte Carlo docking-minimization simulation. As possible guests of inclusion complexation for the host cyclic oligosaccharides, two functional moieties of the suggested solution structure of paclitaxel were used where one is the C-3'N benzoyl moiety (B-ring) and the other is a hydrophobic (HP) cluster site among the C-3' phenyl (C-ring), C-2 benzoate (A-ring), and C-4 acetoxy moieties. The energetic preference of inclusion complexation of DM-beta-CD over beta-CD was analyzed on the basis of more efficient partitioning process of DM-beta-CD into the hydrophobic cluster site of the paclitaxel.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890892     DOI: 10.1016/s0008-6215(02)00015-0

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

1.  Molecular dynamics simulation of cyclosophoroheptadecaose (Cys-A).

Authors:  Hyunmyung Kim; Karpjoo Jeong; Sangsan Lee; Seunho Jung
Journal:  J Comput Aided Mol Des       Date:  2002 Aug-Sep       Impact factor: 3.686

2.  Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network.

Authors:  Tianyuan Fan; Kozo Takayama; Yoshiyuki Hattori; Yoshie Maitani
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

3.  The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.

Authors:  Ya-Jing Ye; Yun Wang; Kai-Yan Lou; Yan-Zuo Chen; Rongjun Chen; Feng Gao
Journal:  Int J Nanomedicine       Date:  2015-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.